Literature DB >> 26943842

Pipeline Embolization Device for small paraophthalmic artery aneurysms with an emphasis on the anatomical relationship of ophthalmic artery origin and aneurysm.

Christoph J Griessenauer1, Christopher S Ogilvy1, Paul M Foreman2, Michelle H Chua3, Mark R Harrigan2, Christopher J Stapleton4, Aman B Patel4, Lucy He5, Matthew R Fusco5, J Mocco6, Peter A Winkler7, Apar S Patel1, Ajith J Thomas1.   

Abstract

OBJECTIVE Contemporary treatment for paraophthalmic artery aneurysms includes flow diversion utilizing the Pipeline Embolization Device (PED). Little is known, however, about the potential implications of the anatomical relationship of the ophthalmic artery (OA) origin and aneurysm, especially in smaller aneurysms. METHODS Four major academic institutions in the United States provided data on small paraophthalmic aneurysms (≤ 7 mm) that were treated with PED between 2009 and 2015. The anatomical relationship of OA origin and aneurysm, radiographic outcomes of aneurysm occlusion, and patency of the OA were assessed using digital subtraction angiography. OA origin was classified as follows: Type 1, OA separate from the aneurysm; Type 2, OA from the aneurysm neck; and Type 3, OA from the aneurysm dome. Clinical outcome was assessed using the modified Rankin Scale, and visual deficits were categorized as transient or permanent. RESULTS The cumulative number of small paraophthalmic aneurysms treated with PED between 2009 and 2015 at the 4 participating institutions was 69 in 52 patients (54.1 ± 13.7 years of age) with a male-to-female ratio of 1:12. The distribution of OA origin was 72.5% for Type 1, 17.4% for Type 2, and 10.1% for Type 3. Radiographic outcome at the last follow-up (median 11.5 months) was available for 54 aneurysms (78.3%) with complete, near-complete, and incomplete occlusion rates of 81.5%, 5.6%, and 12.9%, respectively. Two aneurysms (3%) resulted in transient visual deficits, and no patient experienced a permanent visual deficit. At the last follow-up, the OA was patent in 96.8% of treated aneurysms. Type 3 OA origin was associated with a lower rate of complete aneurysm occlusion (p = 0.0297), demonstrating a trend toward visual deficits (p = 0.0797) and a lower rate of OA patency (p = 0.0783). CONCLUSIONS Pipeline embolization treatment of small paraophthalmic aneurysms is safe and effective. An aneurysm where the OA arises from the aneurysm dome may be associated with lower rates of aneurysm occlusion, OA patency, and higher rates of transient visual deficits.

Entities:  

Keywords:  ICA = internal carotid artery; OA = ophthalmic artery; PED = Pipeline Embolization Device; Pipeline Embolization Device; SAH = subarachnoid hemorrhage; UCAS = Unruptured Cerebral Aneurysm Study; aneurysm; mRS = modified Rankin Scale; occlusion; ophthalmic artery; outcome; patency; vascular disorders; vision

Mesh:

Year:  2016        PMID: 26943842     DOI: 10.3171/2015.12.JNS152499

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  14 in total

1.  Risk of Branch Occlusion and Ischemic Complications with the Pipeline Embolization Device in the Treatment of Posterior Circulation Aneurysms.

Authors:  N Adeeb; C J Griessenauer; A A Dmytriw; H Shallwani; R Gupta; P M Foreman; H Shakir; J Moore; N Limbucci; S Mangiafico; A Kumar; C Michelozzi; Y Zhang; V M Pereira; C C Matouk; M R Harrigan; A H Siddiqui; E I Levy; L Renieri; T R Marotta; C Cognard; C S Ogilvy; A J Thomas
Journal:  AJNR Am J Neuroradiol       Date:  2018-06-07       Impact factor: 3.825

Review 2.  Role of the ophthalmic artery in the endovascular treatment for intracranial vascular diseases.

Authors:  Kun Hou; Wei Wu; Ying Liu; Lai Qu; Baofeng Xu; Jinlu Yu
Journal:  Acta Neurol Belg       Date:  2021-01-05       Impact factor: 2.396

Review 3.  Blood Flow Diversion as a Primary Treatment Method for Ruptured Brain Aneurysms-Concerns, Controversy, and Future Directions.

Authors:  Brian P Walcott; Matthew J Koch; Christopher J Stapleton; Aman B Patel
Journal:  Neurocrit Care       Date:  2017-06       Impact factor: 3.210

4.  Open-cell stent and use of cone-beam CT enables a safe and effective coil embolization of true ophthalmic artery and anterior choroidal artery aneurysms with preservation of parent vessel: Clinical and angiographic results.

Authors:  Samuel Y Hou; Anna Luisa Kühn; Ajit S Puri; Ajay K Wakhloo
Journal:  Interv Neuroradiol       Date:  2017-12-14       Impact factor: 1.610

5.  Implications of the Collar Sign in Incompletely Occluded Aneurysms after Pipeline Embolization Device Implantation: A Follow-Up Study.

Authors:  S Gomez-Paz; Y Akamatsu; J M Moore; C S Ogilvy; A J Thomas; C J Griessenauer
Journal:  AJNR Am J Neuroradiol       Date:  2020-02-13       Impact factor: 3.825

6.  Collar Sign in Incompletely Occluded Aneurysms after Pipeline Embolization: Evaluation with Angiography and Optical Coherence Tomography.

Authors:  C J Griessenauer; R Gupta; S Shi; A Alturki; R Motiei-Langroudi; N Adeeb; C S Ogilvy; A J Thomas
Journal:  AJNR Am J Neuroradiol       Date:  2016-11-10       Impact factor: 3.825

7.  Incomplete occlusion and visual symptoms of peri-ophthalmic aneurysm after treatment with a pipeline embolization device: a multi-center cohort study.

Authors:  Chao Xu; Pei Wu; Bowen Sun; Shancai Xu; Bin Luo; Xinjian Yang; Huaizhang Shi
Journal:  Acta Neurochir (Wien)       Date:  2022-05-13       Impact factor: 2.816

8.  Acute retinal hemorrhage after Pipeline embolization device placement for treatment of ophthalmic segment aneurysm: A case report.

Authors:  Nimer Adeeb; Justin Moore; Christoph J Griessenauer; Raghav Gupta; Ahad A Fazelat; Christopher S Ogilvy; Ajith J Thomas
Journal:  Interv Neuroradiol       Date:  2018-05-12       Impact factor: 1.610

Review 9.  Treatment of Middle Cerebral Artery Aneurysms with Flow-Diverter Stents: A Systematic Review and Meta-Analysis.

Authors:  F Cagnazzo; D Mantilla; P-H Lefevre; C Dargazanli; G Gascou; V Costalat
Journal:  AJNR Am J Neuroradiol       Date:  2017-10-05       Impact factor: 3.825

10.  Ex-vivo release of Pipeline Embolization Device polytetrafluoroethylene (PTFE) sleeves for improved distal landing zone accuracy in-vivo: A technical note.

Authors:  Christoph J Griessenauer; Raghav Gupta; Justin Moore; Ajith J Thomas; Christopher S Ogilvy
Journal:  Interv Neuroradiol       Date:  2016-07-28       Impact factor: 1.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.